Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-Infected Infants and Children

• Published in: Antimicrobial Agents and Chemotherapy Vol. 42; no. 6; pp. 1315 - 1318
• Main Authors: HUGHES, W, DORENBAUM, A, SADLER, B, YOGEV, R, BEAUCHAMP, B, JING XU, MCNAMARA, J, MOYE, J, PURDUE, L, VAN DYKE, R, ROGERS, M
• Format: Journal Article
• Language: English
• Published: Washington, DC American Society for Microbiology 01.06.1998
• Subjects: AIDS-Related Opportunistic Infections; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antifungal Agents; Antiparasitic agents; Biological and medical sciences; Medical sciences; Naphthoquinones; Pharmacology; Pharmacology. Drug treatments; Human; Atovaquone; Toxicity; Single dose; Oral administration; Retroviridae; Infant; Pneumocystis carinii; Bioavailability; Lentivirus; Fungi; Virus; Infection; Antiprotozoal agent; Antibiotic; Parasiticid; Phase I trial; Fungi Imperfecti; Human immunodeficiency virus; Daily dose; Pharmacokinetics; Child; Thallophyta

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...